Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06676007
What this trial is testing

A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)Early Initial Therapy
Sichuan Provincial People's Hospital 200
Post-approval studies (Phase 4)Ended earlyNCT01129557
What this trial is testing

Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Who this might be right for
Proteinuric Kidney DiseaseDiabetic NephropathyHypertensive Nephrosclerosis+4 more
Columbia University 46
Very early researchEnrolling By InvitationNCT07750249
What this trial is testing

The MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo. Administered Orally Once Daily With Standard Care, it Aims to Prevent CKD Progression in Biopsy-proven IgA Nephropathy by Modulating the Gut Microbiome.

Who this might be right for
Primary IgA Nephropathy
University Hospital, Martin 120
Very early researchEnrolling By InvitationNCT07135219
What this trial is testing

Cizutamig in Patients With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Peking University First Hospital 15
Not applicableActive Not RecruitingNCT07816874
What this trial is testing

Model Development and Application Based on Renal Pathology Images

Who this might be right for
Kidney Diseases, ChronicGlomerular DiseasesTubulointerstitial Kidney Diseases+2 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 8,000
Testing effectiveness (Phase 2)Looking for participantsNCT07606352
What this trial is testing

Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgAN
Sitala Bio LTD 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07820995
What this trial is testing

Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)Immunoglobulin A Nephropathy (IgAN)
University of Illinois at Chicago 20
Not applicableStudy completedNCT00301600
What this trial is testing

Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy

Who this might be right for
IGA Nephropathy
Nanjing University School of Medicine 40
Testing effectiveness (Phase 2)Looking for participantsNCT07354932
What this trial is testing

SHR-2173 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 84
Not applicableUnknownNCT05797051
What this trial is testing

Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

Who this might be right for
Glomerulonephritis, IGAGlomerulonephritis, MembranousDiabetic Nephropathies+2 more
Qianfoshan Hospital 80
Early research (Phase 1)Study completedNCT04887532
What this trial is testing

A Trial of HR19042 Capsule in Healthy Chinese Subjects

Who this might be right for
Primary IgA Nephropathy
Jiangsu HengRui Medicine Co., Ltd. 12
Not applicableAvailableNCT07319585
What this trial is testing

Managed Access Programs for EXV811, Atrasentan

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00554502
What this trial is testing

Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy

Who this might be right for
IgA Nephropathy
RWTH Aachen University 148
Testing effectiveness (Phase 2)Looking for participantsNCT07182227
What this trial is testing

PS-002 for the Treatment of IgA Nephropathy in Adults

Who this might be right for
Immunoglobulin A (IgA) Nephropathy
Purespring Therapeutics Limited 32
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Post-approval studies (Phase 4)Looking for participantsNCT07030894
What this trial is testing

Nefecon and Ambrisentan in IgA Nephropathy

Who this might be right for
IgA NephropathyChronic Kidney DiseaseProteinuria
The First Hospital of Jilin University 129
Testing effectiveness (Phase 2)Study completedNCT06670352
What this trial is testing

Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 87
Testing effectiveness (Phase 2)Looking for participantsNCT07305974
What this trial is testing

A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. 30
Early research (Phase 1)Looking for participantsNCT05942625
What this trial is testing

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

Who this might be right for
IgA NephropathyFocal Segmental Glomerulosclerosis
Hansoh BioMedical R&D Company 84
Next Page